BETNESOL 0.50 mg, effervescent tablet 30 tablets
Active ingredients: Betamethasone sodium phosphate, Betamethasone
Commercialized according to BDPMDispensing in France: Prescription only
Effervescent tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BETNESOL 0,50 mg, comprimé effervescent
- Pharmaceutical form
- comprimé effervescent(e)
- Route of administration
- orale
- Presentation description
- 3 film(s) thermosoudé(s) complexe aluminium polyéthylène de 10 comprimé(s)
- Marketing authorisation holder
- ALFASIGMA (ITALIE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Oct 1963
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66322048CIP73010973CIP133400930109731Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BÉTAMÉTHASONEcomprimé | 0,5000 mg · un comprimé | FT |
| BÉTAMETHASONE (PHOSPHATE DE) ET DE DISODIUMcomprimé | 0,6578 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.